Correlation Between Beam Therapeutics and 89bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and 89bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and 89bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and 89bio Inc, you can compare the effects of market volatilities on Beam Therapeutics and 89bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of 89bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and 89bio.

Diversification Opportunities for Beam Therapeutics and 89bio

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Beam and 89bio is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and 89bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 89bio Inc and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with 89bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 89bio Inc has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and 89bio go up and down completely randomly.

Pair Corralation between Beam Therapeutics and 89bio

Given the investment horizon of 90 days Beam Therapeutics is expected to generate 1.25 times more return on investment than 89bio. However, Beam Therapeutics is 1.25 times more volatile than 89bio Inc. It trades about 0.18 of its potential returns per unit of risk. 89bio Inc is currently generating about 0.0 per unit of risk. If you would invest  2,293  in Beam Therapeutics on September 2, 2024 and sell it today you would earn a total of  444.00  from holding Beam Therapeutics or generate 19.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Beam Therapeutics  vs.  89bio Inc

 Performance 
       Timeline  
Beam Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
89bio Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in 89bio Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, 89bio may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Beam Therapeutics and 89bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beam Therapeutics and 89bio

The main advantage of trading using opposite Beam Therapeutics and 89bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, 89bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will offset losses from the drop in 89bio's long position.
The idea behind Beam Therapeutics and 89bio Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Correlations
Find global opportunities by holding instruments from different markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk